PDQ Updates for Health Professionals

You are subscribed to PDQ Updates for Health Professionals. NCI newly published or updated these health professional summaries within the last week. Adult Treatment Breast Cancer Treatment This summary has been extensively revised. Pediatric Treatment Childhood Acute Lymphoblastic Leukemia Treatment We updated information on Cytogenetics/Genomics of Childhood ALL Central Nervous System (CNS)-Directed Therapy for Childhood ALL Treatment of Relapsed Childhood ALL Childhood Laryngeal Tumors Treatment We updated information on Childhood Laryngeal Papillomatosis Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment We updated information on Childhood Medulloblastoma Childhood Myelodysplastic Neoplasms Treatment We updated information on Treatment of Childhood Myelodysplastic Neoplasms (MDS) Childhood Pulmonary Inflammatory Myofibroblastic Tumors Treatment We updated information on Treatment of Childhood Pulmonary Inflammatory Myofibroblastic Tumors (IMTs) Childhood Thyroid Cancer Treatment We updated information on Incidence Histology Clinical Presentation and Prognostic Factors Complications, Graft-Versus-Host Disease, and Late Effects After Pediatric Hematopoietic Stem Cell Transplant We updated information on Hematopoietic Stem Cell Transplant (HSCT)–Related Acute Complications Late Effects After Hematopoietic Stem Cell Transplant (HSCT) in Children Late Effects of Treatment for Childhood Cancer We updated information on Subsequent Neoplasms (SNs) Late Effects of the Central Nervous System (CNS) Late Effects of the Digestive System Late Effects of the Endocrine System Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment We updated information on General Information About Osteosarcoma and Undifferentiated Pleomorphic Sarcoma (UPS) (Formerly Called Malignant Fibrous Histiocytoma [MFH]) of Bone Treatment of Localized Osteosarcoma and UPS of Bone Treatment of Recurrent Osteosarcoma and UPS of Bone Screening and Prevention Liver (Hepatocellular) Cancer Prevention We updated information on Incidence, Mortality, and Survival Interventions With Adequate Evidence of Decreased Risk of HCC Interventions with Inadequate Evidence of Decreased Risk of HCC Prostate Cancer Screening We updated information on Screening by Serum Prostate-Specific Antigen (PSA) Learn about the PDQ health professional summaries and our editorial process

Stay Connected with the National Cancer Institute
Chat with us: LiveHelp  Call us: 1-800-4-CANCER (1-800-422-6237) SUBSCRIBER SERVICES: Manage Subscriptions  |  Help

 

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud on behalf of: National Cancer Institute · BG 9609 MSC 9760 · 9609 Medical Center Drive · Bethesda, MD 20892